7.713.3Non-cash accretion and fair value adjustments of contingent consideration liability
5.88.2Clean energy investment pre-tax loss (b)
4.44.2Acquisition related costs (primarily included in selling, general and administrative expense)
19.4—Restructuring and other special items included in:Cost of sales
10.92.2Research and development expense
23.31.4Selling, general and administrative expense
24.024.4Other income, net
6.82.3Tax effect of the above items and other income tax related items
(57.2)(50.3)Adjusted net earnings attributable to Mylan Inc. and adjusted diluted EPS
0.52Weighted average diluted common shares outstanding
Purchase accounting related amortization expense for the three months ended March 31, 2013 includes $5.1 million of in-process research and development asset impairment charges.
Adjustment represents exclusion of the pre-tax loss related to Mylan's investment in a clean energy partnership, the activities of which qualify for income tax credits under section 45 of the Internal Revenue Code. Amount is included in other income (expense), net. Certain insignificant prior period amounts of other revenue, cost of sales, operating expenses and the related EBITDA and Adjusted EBITDA have been reclassified to other income (expense), net to conform to the presentation for the current period. The reclassifications had no impact on the previously reported net earnings attributable to Mylan Inc. common shareholders.
Below is a reconciliation of GAAP net earnings attributable to Mylan Inc. to adjusted EBITDA for the three months ended March 31, 2013 and 2012 (in millions):
Three Months EndedMarch 31,20132012GAAP net earnings attributable to Mylan Inc.
|SOURCE Mylan Inc.|
Copyright©2012 PR Newswire.
All rights reserved